FDA Adds Rare Vision-Loss Warning to Popular GLP-1 Drugs

• The Food and Drug Administration is adding a warning about rare vision loss to popular GLP-1 drugs, the widely prescribed medications used for diabetes and weight loss.
• The Associated Press reports the label change reflects newly reviewed safety data tied to the drug class.
• Patients taking these medications should be aware of the potential risk and talk with their doctors about any changes in their eyesight.

AI-generated briefing. Every claim links to the coverage below.